Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Delta 9 Cannabis Inc. stock logo
DN
Delta 9 Cannabis
C$0.00
C$0.01
C$0.07
C$3.02M1.21813,175 shs1.07 million shs
The Flowr Co. stock logo
FLWR
Flowr
C$0.03
C$0.02
C$0.02
C$0.11
C$10.66MN/A302,866 shs29,006 shs
Khiron Life Sciences Corp. stock logo
KHRN
Khiron Life Sciences
C$0.04
C$0.04
C$0.04
C$0.21
C$9.30M2.64256,268 shs24,000 shs
Medicure Inc. stock logo
MPH
Medicure
C$1.00
-10.7%
C$1.15
C$0.63
C$1.33
C$10.44M1.0737644,582 shs15,500 shs
7 Stocks to Buy And Hold Forever Cover

Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Delta 9 Cannabis Inc. stock logo
DN
Delta 9 Cannabis
0.00%0.00%0.00%0.00%0.00%
The Flowr Co. stock logo
FLWR
Flowr
0.00%0.00%0.00%0.00%0.00%
Khiron Life Sciences Corp. stock logo
KHRN
Khiron Life Sciences
0.00%0.00%0.00%0.00%0.00%
Medicure Inc. stock logo
MPH
Medicure
0.00%-15.15%-2.61%+5.66%+10.89%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Delta 9 Cannabis Inc. stock logo
DN
Delta 9 Cannabis
C$0.00
C$0.01
C$0.07
C$3.02M1.21813,175 shs1.07 million shs
The Flowr Co. stock logo
FLWR
Flowr
C$0.03
C$0.02
C$0.02
C$0.11
C$10.66MN/A302,866 shs29,006 shs
Khiron Life Sciences Corp. stock logo
KHRN
Khiron Life Sciences
C$0.04
C$0.04
C$0.04
C$0.21
C$9.30M2.64256,268 shs24,000 shs
Medicure Inc. stock logo
MPH
Medicure
C$1.00
-10.7%
C$1.15
C$0.63
C$1.33
C$10.44M1.0737644,582 shs15,500 shs
7 Stocks to Buy And Hold Forever Cover

Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Delta 9 Cannabis Inc. stock logo
DN
Delta 9 Cannabis
0.00%0.00%0.00%0.00%0.00%
The Flowr Co. stock logo
FLWR
Flowr
0.00%0.00%0.00%0.00%0.00%
Khiron Life Sciences Corp. stock logo
KHRN
Khiron Life Sciences
0.00%0.00%0.00%0.00%0.00%
Medicure Inc. stock logo
MPH
Medicure
0.00%-15.15%-2.61%+5.66%+10.89%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Delta 9 Cannabis Inc. stock logo
DN
Delta 9 Cannabis
0.00
N/AN/AN/A
The Flowr Co. stock logo
FLWR
Flowr
0.00
N/AN/AN/A
Khiron Life Sciences Corp. stock logo
KHRN
Khiron Life Sciences
0.00
N/AN/AN/A
Medicure Inc. stock logo
MPH
Medicure
0.00
N/AN/AN/A
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Delta 9 Cannabis Inc. stock logo
DN
Delta 9 Cannabis
C$70.65M0.00N/A4.47C($0.04) per share0.00
The Flowr Co. stock logo
FLWR
Flowr
C$12.92M0.83C$0.00 per share8.33C$0.00 per share-25.00
Khiron Life Sciences Corp. stock logo
KHRN
Khiron Life Sciences
C$18.08M0.51C$0.01 per share6.67C$0.20 per share0.20
Medicure Inc. stock logo
MPH
Medicure
C$23.20M0.45C$0.40 per share2.49C$1.91 per share0.52
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Delta 9 Cannabis Inc. stock logo
DN
Delta 9 Cannabis
-C$19.60M-C$0.10N/AN/AN/A-27.74%-29,673.63%-12.08%N/A
The Flowr Co. stock logo
FLWR
Flowr
N/A-C$0.21N/AN/AN/AN/AN/AN/A
Khiron Life Sciences Corp. stock logo
KHRN
Khiron Life Sciences
-C$46.80M-C$0.20N/AN/A-258.92%-68.62%-20.79%N/A
Medicure Inc. stock logo
MPH
Medicure
-C$2.03M-C$0.13N/AN/A-9.65%-10.18%-5.63%N/A
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Delta 9 Cannabis Inc. stock logo
DN
Delta 9 Cannabis
N/AN/AN/AN/AN/A
The Flowr Co. stock logo
FLWR
Flowr
N/AN/AN/AN/AN/A
Khiron Life Sciences Corp. stock logo
KHRN
Khiron Life Sciences
N/AN/AN/AN/AN/A
Medicure Inc. stock logo
MPH
Medicure
N/A2.24%N/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Delta 9 Cannabis Inc. stock logo
DN
Delta 9 Cannabis
2,156.19
0.30
0.14
The Flowr Co. stock logo
FLWR
Flowr
71.27
1.13
0.15
Khiron Life Sciences Corp. stock logo
KHRN
Khiron Life Sciences
6.68
3.08
0.72
Medicure Inc. stock logo
MPH
Medicure
4.65
2.03
1.29

Institutional Ownership

CompanyInstitutional Ownership
Delta 9 Cannabis Inc. stock logo
DN
Delta 9 Cannabis
N/A
The Flowr Co. stock logo
FLWR
Flowr
N/A
Khiron Life Sciences Corp. stock logo
KHRN
Khiron Life Sciences
0.22%
Medicure Inc. stock logo
MPH
Medicure
4.85%

Insider Ownership

CompanyInsider Ownership
Delta 9 Cannabis Inc. stock logo
DN
Delta 9 Cannabis
14.51%
The Flowr Co. stock logo
FLWR
Flowr
N/A
Khiron Life Sciences Corp. stock logo
KHRN
Khiron Life Sciences
4.64%
Medicure Inc. stock logo
MPH
Medicure
26.68%
CompanyEmployeesShares OutstandingFree FloatOptionable
Delta 9 Cannabis Inc. stock logo
DN
Delta 9 Cannabis
200302.18 millionN/ANot Optionable
The Flowr Co. stock logo
FLWR
Flowr
186426.47 millionN/ANot Optionable
Khiron Life Sciences Corp. stock logo
KHRN
Khiron Life Sciences
N/A232.41 millionN/ANot Optionable
Medicure Inc. stock logo
MPH
Medicure
N/A10.44 millionN/ANot Optionable

Recent News About These Companies

Medicure to Present Financial Results on August 21…
Medicure Inc. to Announce Q2 2025 Financial Results
Medicure Inc. (NGQ1.F)
Medicure Inc. (MPH.V)
MPH:CA Medicure Inc.

Media Sentiment Over Time

Top Headlines

View All Headlines
Delta 9 Cannabis stock logo

Delta 9 Cannabis TSE:DN

Delta 9 Cannabis Inc., together with its subsidiaries, operates as an integrated cannabis company. The company engages in the cultivation, processing, extraction, wholesale distribution, retail, and sale of medical and recreational cannabis products. Its products include dried cannabis flowers, pre-rolls, and dried sift cannabis, as well as oils, and extracted and derivative products. The company also offers grow pods and live plants to other licensed and pre-licensed companies. In addition, it operates as a medical clinic that provides physician consultation services to patients seeking a medical recommendation for a cannabis prescription. The company operates retail stores under the Delta 9 brand name across the Canadian provinces. It also exports its products to Australia. The company was incorporated in 2001 and is based in Vancouver, Canada.

Flowr stock logo

Flowr CVE:FLWR

C$0.02 0.00 (0.00%)
As of 10/17/2022

The Flowr Corporation cultivates, produces, and sells cannabis in Canada. The company offers dried flowers and pre-rolls. It also has operations in Canada, Portugal, and the European Union. The company was incorporated in 2016 and is headquartered in Toronto, Canada.

Khiron Life Sciences stock logo

Khiron Life Sciences CVE:KHRN

C$0.04 0.00 (0.00%)
As of 05/5/2023

Khiron Life Sciences Corp. operates as an integrated medical and cannabis company in Latin America and Europe. It operates through Health Services, Medical Cannabis Products, and Wellbeing Products segments. The company focuses on the cultivation, production, distribution, and export of tetrahydrocannabinol and cannabidiol (CBD) medical cannabis. It also operates a network of health centers and satellite clinics under the ILANS and Zerenia brands; develops CBD-based cosmeceutical products under the Kuida brand name; and operates Zerenia clinic in Medellin and Peru. Khiron Life Sciences Corp. was incorporated in 2012 and is headquartered in Vancouver, Canada.

Medicure stock logo

Medicure CVE:MPH

C$1.00 -0.12 (-10.71%)
As of 03:44 PM Eastern

Medicure Inc., a biopharmaceutical company, engages in the research, development, and commercialization of human therapies in the United States. The company markets and distributes AGGRASTAT injection, a glycoprotein GP IIb/IIIa receptor antagonist for the treatment of acute coronary syndrome, including unstable angina and non-Q-wave myocardial infarction. It also offers ZYPITAMAG to treat patients with primary hyperlipidemia or mixed dyslipidemia. In addition, the company is developing Sodium Nitroprusside injection, and Generic ANDA 2 and 3 for acute cardiology; and TARDOCAL, to treat neurological indications. It offers products through retail and mail order pharmacies. The company was incorporated in 1997 and is headquartered in Winnipeg, Canada.